Benzinga's Top Downgrades
June 27, 2014 at 09:28 AM EDT
Analysts at Raymond James downgraded Covidien plc (NYSE: COV) from “strong buy” to “outperform.” The target price for Covidien has been ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.